Viewing StudyNCT00461058

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 5:28 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00461058
Status: COMPLETED
Last Update Posted: 2016-08-05
First Post: 2007-04-16
Brief Title: A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association NYHA Class II Heart Failure
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords: